Angiogenesis modulates adipogenesis and obesity

Journal of Clinical Investigation

Volumn 117, Issue 9, 2007, Pages 2362-2368

  Cao, Yihai ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOSTATIN; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; FUMAGILLOL CHLOROACETYLCARBAMATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEPTIN; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; CELL MIGRATION; ENDOTHELIUM CELL; HUMAN; NEOVASCULARIZATION (PATHOLOGY); OBESITY; PRIORITY JOURNAL; REVIEW;

ADIPOCYTES; ADIPOGENESIS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL COMMUNICATION; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY;

EID: 34848851922     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32239     Document Type: Review

References (115)

1. Korner, J., and Aronne, L.J. 2003. The emerging science of body weight regulation and its impact on obesity treatment. J. Clin. Invest. 111:565-570. doi:10.1172/JCI200317953.
2. Friedman, J.M. 2000. Obesity in the new millennium. Nature. 404:632-634.
3. Kopelman, P.G. 2000. Obesity as a medical problem. Nature. 404:635-643.
4. Roth, J., Qiang, X., Marban, S.L., Redelt, H., and Lowell, B.C. 2004. The obesity pandemic: where have we been and where are we going? Obes. Res. 12(Suppl. 2):88S-101S.
5. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature. 438:932-936.
6. Dvorak, H.F. 2005. Angiogenesis: update 2005. J. Thromb. Haemost. 3:1835-1842.
7. Ferrara, N., and Kerbel, R.S. 2005. Angiogenesis as a therapeutic target. Nature. 438:967-974.
8. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
9. Folkman, J. 1995. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1757-1763.
10. Lambert, P.D., et al. 2001. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc. Natl. Acad. Sci. U. S. A. 98:4652-4657.
11. Lyden, D., et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:1194-1201.
12. McDonald, D.M., and Choyke, P.L. 2003. Imaging of angiogenesis: from microscope to clinic. Nat. Med. 9:713-725.
13. Bouloumie, A., Lolmede, K., Sengenes, C., Galitzky, J., and Lafontan, M. 2002. Angiogenesis in adipose tissue. Ann. Endocrinol. (Paris). 63:91-95.
14. Crandall, D.L., Hausman, G.J., and Kral, J.G. 1997. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation. 4:211-232.
15. Silverman, K.J., et al. 1988. Angiogenic activity of adipose tissue. Biochem. Biophys. Res. Commun. 153:347-352.
16. Brakenhielm, E., et al. 2004. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 94:1579-1588.
17. Neels, J.G., Thinnes, T., and Loskutoff, D.J. 2004. Angiogenesis in an in vivo model of adipose tissue development. FASEB J. 18:983-985.
18. Rupnick, M.A., et al. 2002. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. U. S. A. 99:10730-10735.
19. Lau, D.C. 1990. Nature and nurture in adipocyte development and growth. Int. J. Obes. 14(Suppl. 3):153-157.
20. Lau, D.C., Shillabeer, G., Wong, K.L., Tough, S.C., and Russell, J.C. 1990. Influence of paracrine factors on preadipocyte replication and differentiation. Int. J. Obes. 14(Suppl. 3):193-201.
21. Planat-Benard, V., et al. 2004. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 109:656-663.
22. Cao, Y., et al. 2005. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem. Biophys. Res. Commun. 332:370-379.
23. Himms-Hagen, J., and Desautels, M. 1978. A mitochondrial defect in brown adipose tissue of the obese (ob/ob) mouse: reduced binding of purine nucleotides and a failure to respond to cold by an increase in binding. Biochem. Biophys. Res. Commun. 83:628-634.
24. Tonello, C., Dioni, L., Briscini, L., Nisoli, E., and Carruba, M.O. 1998. SR59230A blocks beta3-adrenoceptor-linked modulation of upcoupling protein-1 and leptin in rat brown adipocytes. Eur. J. Pharmacol. 352:125-129.
25. Bukowiecki, L., et al. 1980. Mechanism of enhanced lipolysis in adipose tissue of exercise-trained rats. Am. J. Physiol. 239:E422-E429.
26. Cannon, B., Jacobsson, A., Rehnmark, S., and Nedergaard, J. 1996. Signal transduction in brown adipose tissue recruitment: noradrenaline and beyond. Int. J. Obes. Relat. Metab. Disord. 20(Suppl. 3):S36-S42.
27. Beck, C.S. 1935. Revascularization of the heart by vein graft from aorta to coronary sinus. Ann. Surg. 102:801-813.
28. Vineberg, A.M., et al. 1965. Myocardial revascularization by omental graft without pedicle: experimental background and report on 25 cases followed 6 to 16 months. J. Thorac. Cardiovasc. Surg. 49:103-129.
29. Castellot, J.J., Jr., Karnovsky, M.J., and Spiegelman, B.M. 1982. Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc. Natl. Acad. Sci. U. S. A. 79:5597-5601.
30. Goldsmith, H.S., Griffith, A.L., Kupferman, A., and Catsimpoolas, N. 1984. Lipid angiogenic factor from omentum. JAMA. 252:2034-2036.
31. Li, J., Yu, X., Pan, W., and Unger, R.H. 2002. Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am. J. Physiol. Endocrinol. Metab. 282:E1334-E1341.
32. Zhang, Q.X., et al. 1997. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J. Surg. Res. 67:147-154.
33. Hutley, L.J., et al. 2001. Human adipose tissue endothelial cells promote preadipocyte proliferation. Am. J. Physiol. Endocrinol. Metab. 281:E1037-E1044.
34. Varzaneh, F.E., Shillabeer, G., Wong, K.L., and Lau, D.C. 1994. Extracellular matrix components secreted by microvascular endothelial cells stimulate preadipocyte differentiation in vitro. Metabolism. 43:906-912.
35. Hausman, G.J., and Richardson, L.R. 1982. Histochemical and ultrastructural analysis of developing adipocytes in the fetal pig. Acta Anat. (Basel). 114:228-247.
36. Crandall, D.L., Busler, D.E., McHendry-Rinde, B., Groeling, T.M., and Kral, J.G. 2000. Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1. J. Clin. Endocrinol. Metab. 85:2609-2614.
37. Fukumura, D., et al. 2003. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ. Res. 93:e88-e97.
38. Panigrahy, D., et al. 2002. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J. Clin. Invest. 110:923-932. doi:10.1172/JCI200215634.
39. Ren, D., Collingwood, T.N., Rebar, E.J., Wolffe, A.P., and Camp, H.S. 2002. PPARgamma knockdown by engineered transcription factors: exogenous PPAR-gamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev. 16:27-32.
40. Rosen, E.D., et al. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell. 4:611-617.
41. Xin, H., Geng, Y., Pramanik, R., and Choubey, D. 2003. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival. J. Cell. Biochem. 88:191-204.
42. Kawaguchi, N., et al. 2002. ADAM 12 protease induces adipogenesis in transgenic mice. Am. J. Pathol. 160:1895-1903.
43. Bouloumie, A., Sengenes, C., Portolan, G., Galitzky, J., and Lafontan, M. 2001. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes. 50:2080-2086.
44. Bergers, G., et al. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:737-744.
45. Christiaens, V., and Lijnen, H.R. 2006. Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch. Physiol. Biochem. 112:254-259.
46. Maquoi, E., Demeulemeester, D., Voros, G., Collen, D., and Lijnen, H.R. 2003. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb. Haemost. 89:696-704.
47. Lijnen, H.R., Demeulemeester, D., Van Hoef, B., Collen, D., and Maquoi, E. 2003. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb. Haemost. 89:249-255.
48. Lijnen, H.R., et al. 2002. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler. Thromb. Vasc. Biol. 22:374-379.
49. Fitzpatrick, T.E., and Graham, C.H. 1998. Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp. Cell Res. 245:155-162.
50. Scannell, G., et al. 1995. Hypoxia-induced alterations of neutrophil membrane receptors. J. Surg. Res. 59:141-145.
51. Cho, C.H., et al. 2007. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ. Res. 100:e47-e57.
52. Rehman, J., et al. 2004. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 109:1292- 1298.
53. Cao, Y. 2005. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat. Rev. Cancer. 5:735-743.
54. Baillargeon, J., and Rose, D.P. 2006. Obesity, adipokines, and prostate cancer (review). Int. J. Oncol. 28:737-745.
55. Friedman, J.M., and Halaas, J.L. 1998. Leptin and the regulation of body weight in mammals. Nature. 395:763-770.
56. Hiraoka, Y., et al. 2006. In situ regeneration of adipose tissue in rat fat pad by combining a collagen scaffold with gelatin microspheres containing basic fibroblast growth factor. Tissue Eng. 12:1475-1487.
57. Kuo, L.E., and Zukowska, Z. 2007. Stress, NPY and vascular remodeling: Implications for stress-related diseases. Peptides. 28:435-440.
58. Lijnen, H.R., et al. 2006. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes. 55:2698-2704.
59. Mu, H., et al. 2006. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc. Res. 70:146-157.
60. Saiki, A., Watanabe, F., Murano, T., Miyashita, Y., and Shirai, K. 2006. Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro. Int. J. Obes. (Lond.) 30:1676-1684.
61. Samad, F., Pandey, M., and Loskutoff, D.J. 1998. Tissue factor gene expression in the adipose tissues of obese mice. Proc. Natl. Acad. Sci. U. S. A. 95:7591-7596.
62. Voros, G., et al. 2005. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology. 146:4545-4554.
63. Dobson, D.E., et al. 1990. 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell. 61:223-230.
64. Wilkison, W.O., Choy, L., and Spiegelman, B.M. 1991. Biosynthetic regulation of monobutyrin, an adipocyte-secreted lipid with angiogenic activity. J. Biol. Chem. 266:16886-16891.
65. Wellen, K.E., and Hotamisligil, G.S. 2003. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112:1785-1788. doi:10.1172/JCI200320514.
66. Wellen, K.E., and Hotamisligil, G.S. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115:1111-1119. doi:10.1172/ JCI200525102.
67. Sierra-Honigmann, M.R., et al. 1998. Biological action of leptin as an angiogenic factor. Science. 281:1683-1686.
68. Bouloumie, A., Drexler, H.C., Lafontan, M., and Busse, R. 1998. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83:1059-1066.
69. Ring, B.D., et al. 2000. Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology. 141:446-449.
70. Suganami, E., et al. 2004. Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes. 53:2443-2448.
71. Ribatti, D., et al. 2001. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int. J. Mol. Med. 8:265-268.
72. Park, H.Y., et al. 2001. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp. Mol. Med. 33:95-102.
73. Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J., and Cao, Y. 2001. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. U. S. A. 98:6390-6395.
74. Grosfeld, A., et al. 2002. Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia. 45:527-530.
75. Makino, Y., et al. 2001. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature. 414:550-554.
76. Mandriota, S.J., et al. 2002. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell. 1:459-468.
77. Tigno, X.T., Selaru, I.K., Angeloni, S.V., and Hansen, B.C. 2003. Is microvascular flow rate related to ghrelin, leptin and adiponectin levels? Clin. Hemorheol. Microcirc. 29:409-416.
78. Winters, B., et al. 2000. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J. Appl. Physiol. 89:2382-2390.
79. Eriksson, A., et al. 2003. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation. 107:1532-1538.
80. Kamba, T., et al. 2006. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. 290:H560-H576.
81. Henson, M.C., and Castracane, V.D. 2000. Leptin in pregnancy. Biol. Reprod. 63:1219-1228.
82. Matsui, H., et al. 2007. Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci. 80:672-680.
83. Ekstrand, A.J., et al. 2003. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl. Acad. Sci. U. S. A. 100:6033-6038.
84. Lee, E.W., et al. 2003. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J. Clin. Invest. 111:1853-1862. doi:10.1172/JCI200316929.
85. Movafagh, S., Hobson, J.P., Spiegel, S., Kleinman, H.K., and Zukowska, Z. 2006. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 20:1924-1926.
86. Coppack, S.W. 2001. Pro-inflammatory cytokines and adipose tissue. Proc. Nutr. Soc. 60:349-356.
87. Han, R.N., Post, M., Tanswell, A.K., and Lye, S.J. 2003. Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development. Am. J. Respir. Cell Mol. Biol. 28:159-169.
88. Olszanecka-Glinianowicz, M., Zahorska-Markiewicz, B., Zurakowski, A., and Glinianowicz, M. 2005. The role of tumor necrosis factor (TNF-alpha) in control of metabolism [In Polish]. Wiad. Lek. 58:670-674.
89. Shoshani, O., et al. 2005. The effect of interleukin-8 on the viability of injected adipose tissue in nude mice. Plast. Reconstr. Surg. 115:853-859.
90. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259:87-91.
91. Lebrin, F., Deckers, M., Bertolino, P., and Ten Dijke, P. 2005. TGF-beta receptor function in the endothelium. Cardiovasc. Res. 65:599-608.
92. Silha, J.V., Krsek, M., Sucharda, P., and Murphy, L.J. 2005. Angiogenic factors are elevated in overweight and obese individuals. Int. J. Obes. (Lond.) 29:1308-1314.
93. Asano, A., Irie, Y., and Saito, M. 2001. Isoform-specific regulation of vascular endothelial growth factor (VEGF) family mRNA expression in cultured mouse brown adipocytes. Mol. Cell. Endocrinol. 174:71-76.
94. Devy, L., et al. 2002. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16:147-154.
95. Ma, L.J., et al. 2004. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes. 53:336-346.
96. Morange, P.E., et al. 2000. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler. Thromb. Vasc. Biol. 20:1150-1154.
97. Schafer, K., Fujisawa, K., Konstantinides, S., and Loskutoff, D.J. 2001. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J. 15:1840-1842.
98. Lijnen, H.R. 2005. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice. Thromb. Haemost. 93:816-819.
99. Dallabrida, S.M., et al. 2003. Adipose tissue growth and regression are regulated by angiopoietin-1. Biochem. Biophys. Res. Commun. 311:563-571.
100. Yamauchi, T., et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941-946.
101. Arita, Y., et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83.
102. Brakenhielm, E., et al. 2004. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl. Acad. Sci. U. S. A. 101:2476-2481.
103. Maeda, N., et al. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8:731-737.
104. Eriksson, A., et al. 2002. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell. 1:99-108.
105. Inuzuka, H., et al. 1999. Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. Biochem. Biophys. Res. Commun. 265:664-668.
106. Seida, A., et al. 2003. Serum bFGF levels are reduced in Japanese overweight men and restored by a 6-month exercise education. Int. J. Obes. Relat. Metab. Disord. 27:1325-1331.
107. Shang, C.A., Thompson, B.J., Teasdale, R., Brown, R.J., and Waters, M.J. 2002. Genes induced by growth hormone in a model of adipogenic differentiation. Mol. Cell. Endocrinol. 189:213-219.
108. Burton, G.R., Nagarajan, R., Peterson, C.A., and McGehee, R.E., Jr. 2004. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene. 329:167-185.
109. Okuno, M., et al. 2002. Isolation of up- or down-regulated genes in PPARgamma-expressing NIH-3T3 cells during differentiation into adipocytes. FEBS Lett. 519:108-112.
110. O'Reilly, M.S., et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277-285.
111. Yancopoulos, G.D., Klagsbrun, M., and Folkman, J. 1998. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell. 93:661-664.
112. Lawler, J., et al. 1998. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 101:982-992.
113. Voros, G., and Lijnen, H.R. 2006. Deficiency of thrombospondin-1 in mice does not affect adipose tissue development. J. Thromb. Haemost. 4:277-278.
114. Mancuso, M.R., et al. 2006. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J. Clin. Invest. 116:2610-2621. doi:10.1172/JCI24612.
115. Polverino, A., et al. 2006. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Cancer Res. 66:8715-8721.